Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|December 12, 2018
Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterationsRichard J Lin, Caleb Ho, Patrick D Hilden, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 18, 2025
Dermatologic Adverse Events Following CD19-Directed CAR T-Cell Therapy in Hematologic MalignanciesRyan Storgard, Rachel E Reingold, Rose Parisi, et al.
Bone Marrow Transplantation|April 28, 2022
CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosisMariam T Nawas, Jeong-Ok Lee, Jessica Flynn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 24, 2017
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic MalignanciesAnn A Jakubowski, Erica Petrlik, Molly Maloy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2014
Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphomaParastoo B Dahi, Roni Tamari, Sean M Devlin, et al.
Blood Advances|June 23, 2023
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease preventionBetty K Hamilton, Lisa A Rybicki, Hong Li, et al.
Plos Pathogens|August 18, 2023
Pathogenesis and outcome of VA1 astrovirus infection in the human brain are defined by disruption of neural functions and imbalanced host immune responsesOlga A Maximova, Melodie L Weller, Tammy Krogmann, et al.
Blood|January 9, 2015
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphomaAntonio Omuro, Denise D Correa, Lisa M DeAngelis, et al.
Blood Cancer Journal|May 31, 2024
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell TherapyDanai Dima, Al-Ola Abdallah, James A Davis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2013
A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patientsCraig S Sauter, Juliet N Barker, Lauren Lechner, et al.
Pageof 16